Browsing Tag
PureTech Health
6 posts
Seaport Therapeutics seeks $212m IPO as neuropsychiatry biotech window reopens
Seaport’s IPO tests biotech appetite before key depression data. Here’s why SPTX, PureTech, and psychiatry investors are watching.
Why Seaport’s U.S. IPO filing matters now for neuropsychiatric drug development and biotech capital markets
Seaport Therapeutics has filed for a U.S. IPO. Read how its neuropsychiatry pipeline could test biotech investor appetite in 2026.
Digital medicine firm Akili Interactive to merge with Social Capital Suvretta
Akili Interactive, a US-based digital medicine company, has agreed to merge with Social Capital Suvretta Holdings Corp. I…
Microbiome company Vedanta Biosciences raises $68m in Series D
Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D…
PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as…
Vedanta Biosciences secures $27m to propel microbiome drug pipeline
US-based Vedanta Biosciences has raised $27 million in a Series C financing round to accelerate its pioneering work…